Latest SEC Filings

NEXTNRG, INC.NextNRG Reports 35.7% Revenue Growth but $17.4 Million Net Loss in Latest Filing

Revium Rx.Revium Rx Reports 28% Decrease in Net Loss for Q2 2026

RenX Enterprises Corp.RenX Enterprises Reports $4.26M Revenue in Q2 2026, Faces $8.02M Net Loss

Dare Bioscience, Inc.Daré Bioscience Reports Revenue Growth in Q2 2026 Amid Ongoing Losses

HeartBeam, Inc.HeartBeam Reports $5 Million Net Loss in Q2 2026, Highlights Cash Reserves and Strategic Partnerships

Gouverneur Bancorp, Inc./MD/Gouverneur Bancorp Reports Asset Growth and Increased Net Income for June 30, 2026

Vivani Medical, Inc.Vivani Medical Reports $6.4 Million Net Loss for Q2 2026, Plans Merger with ClearOne

Gossamer Bio, Inc.Gossamer Bio Reports $16.9 Million Net Income in Q2 2026, Significant Turnaround from Previous Year

RCM TECHNOLOGIES, INC.RCM Technologies Reports 20% Revenue Growth to $93.8 Million in Q2 Fiscal 2026

RRE Ventures Acquisition Corp.RRE Ventures Acquisition Corp. Reports $1.1M Net Income for Quarter Ending June 30, 2026

Bluerock Homes Trust, Inc.Bluerock Homes Trust Reports $19.3 Million Net Loss and 17% Revenue Growth for First Half of 2026

Triller Group Inc.Triller Group Inc. Reports $60.6 Million Net Loss and $10.3 Million Revenue for First Half of 2026

Sidus Space Inc.Sidus Space Reports 54% Revenue Decline and Net Loss in Q2 2026

BranchOut Food Inc.BranchOut Food Inc. Reports 36% Revenue Growth but Faces Increased Losses in Q2 2026

Akari Therapeutics PlcAkari Therapeutics Reports $4.8 Million Net Loss and Faces Liquidity Challenges in Latest Filing

Heritage Global Inc.Heritage Global Inc. Reports 14% Revenue Decline and $20.9 Million Operating Loss in Q2 2026

International Stem Cell CORPInternational Stem Cell Corporation Reports Q2 2026 Financial Results with Increased Sales but Continued Losses

FB Bancorp, Inc. /MD/FB Bancorp Reports $1.2 Million Net Income for Six Months Ended June 30, 2026

EagleRock Land, LLCEagleRock Land Reports 74% Revenue Growth to $41.5 Million, Net Loss Improves

EXOZYMES INC.eXoZymes Reports $2.88 Million Net Loss in Q2 2026, Increases Cash Reserves

VanEck Bitcoin ETFVanEck Bitcoin ETF Reports 30.63% Decline in Net Assets in Latest 10-Q Filing

VanEck Ethereum ETFVanEck Ethereum ETF Reports 50.61% Decrease in Net Assets in Latest Filing

VanEck Avalanche ETFVanEck Avalanche ETF Reports Significant Asset Growth Despite NAV Decline

JFB Construction HoldingsJFB Construction Holdings Reports 146% Revenue Growth in Q2 2026 Despite Net Loss

VanEck Solana ETFVanEck Solana ETF Reports 39.18% Decline in Net Assets for Six Months Ending June 30, 2026